Gabapentin Tablets — Class II drug recall D-0634-2024
Terminated recall by Granules Pharmaceuticals Inc., reported 2024-08-14, distributed nationwide. Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets
| Recall number | D-0634-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Granules Pharmaceuticals Inc., Chantilly, VA, United States |
| Recall initiated | 2024-07-31 |
| Classified | 2024-08-14 |
| Reported by FDA | 2024-08-14 |
| Terminated | 2025-06-12 |
| Distributed | Nationwide (US) |
| NDC | 70010-0227, 70010-0227-01, 70010-0227-05, 70010-0228, 70010-0228-01, 70010-0228-05 |
| Lot numbers | 1380040A |
| Expiration dates | 2025-07-31 |
Product
Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05
Reason for recall
Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0634-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.